Sources of finance for commercialization. The first big customers to take up the system if it works well are the two participating end- user organizations ORBIS and MRPS. Both are working close with insurance companies for the provision of elderly homecare. Already ORBIS is chosen by CZ, a big insurance company, as the Living Lab to test eHealth solutions. In this role ORBIS will in cooperation with CZ implement eHealth solutions and test them via a model developed by CZ and ORBIS together. In this model research for the eHealth solutions will be done for patient satisfaction, the care paths, clinical efficacy, organisational and care costs. For the eHealth solutions which have good outcomes based on this research, CZ will look for structural financing via the insurance. If Miraculous-Life is successful this can also be further tested via living lab cooperation between ORBIS and CZ. This can be a starting point of stimulating other insurances in other European countries in allocating budget for introducing the system in the elderly care process. The assumption that other organizations will be willing to invest in these developments, is also supported by findings of other projects in this area. Examples: FlevoMind/Connected Vitality Network, a network aiming at remote support of elderly and psychiatric patients, was supported by CMO (‘Centre for social development’ in Flevoland, the Netherlands). Xxxxxxx, a virtual assistant (avatar) for agenda control (reminders of meetings and medicine), control of home automation, video calling with caregivers or relatives, etc., is supported by the province of Gelderland and the city of Deventer (both in the Netherlands). GoOV is an app for assistance in using public transport. Local communities provide funding so that their citizens can get access to this tool. Insurance company CZ has invested in care robot ‘Rose’, also in the Netherlands. This insurance company has dedicated funding (‘CZ Fonds’) for supporting such initiatives. In the Netherlands it is becoming more common that the government or insurance companies pay for automation technology that enables elderly to live independently. Solutions such as a robotic arm or fall detection can even be part of the basic insurance if there is a medical indication22. In Germany the most important deciding factor is the listing in the official aid catalogue (Hilfsmittelkatalog) of care insurance companies that is followed by all public insurers. In the last years various technical systems have been adde...
Sources of finance for commercialization. For each country represented by at least one partner within the project a list of organizations that may be interested in making use of the project outcome will be prepared. We will also investigate what the possibilities for funding for example by insurance companies can be. In case of a successful trial’s outcome, and provided the system meets the needs of residents, the first big customers to take up the system are the two participating end-user organizations ORBIS and MRPS. Those two are working close with insurance companies for the provision of elderly homecare. Already ORBIS, through its participation in other innovative research initiatives, has managed to achieve that a 3% (3.5 million Euro for 2013) of the yearly budget allocated from CZ, one of the biggest insurance companies in the Netherlands, to ORBIS to be used for carrying out research in the introduction of innovative technologies in elderly care reducing thus care cost in the next years. CZ has already agreed that in case of a successful Miraculous-Life trial a financial plan will be put in place for having the system being commercialized and taken up in the ORBIS homecare provision set-up. This can be a starting point of stimulating other insurances in other European countries in allocating budget for introducing the system in the elderly care process. The assumption that other organizations will be willing to invest in these developments, is also supported by findings of similar projects. Examples: FlevoMind/Connected Vitality Network, a network aiming at remote support of elderly and psychiatric patients, was supported by CMO (‘Centre for social development in Flevoland, the Netherlands). Xxxxxxx, a virtual assistant (avatar) for agenda control (reminders of meetings and medicine), control of home automation, video calling with caregivers or relatives, etc., is supported by the province of Gelderland and the city of Deventer (both in the Netherlands). GoOV is an app for assistance in using public transport. Local communities provide funding so that their citizens can get access to this tool. Insurance company CZ has invested in care robot ‘Rose’, also in the Netherlands.
Sources of finance for commercialization. In case of a successful trial’s outcome the first big customers to take up the system are the two participating end-user organizations ORBIS and MRPS. Those two are working close with insurance companies for the provision of elderly homecare. Already ORBIS, through its participation in other innovative research initiatives, has managed to achieve that a 3% (3.5 million Euro for 2013) of the yearly budget allocated from CZ, the biggest Insurance companies in the Netherlands, to ORBIS to be used for carrying out research in the introduction of innovative technologies in elderly care reducing thus care cost in the next years. CZ has already agreed that in case of a successful Miraculous-Life trial a financial plan will be put in place for having the system being commercialized and taken up in the ORBIS homecare provision setup. This can be a starting point of stimulating positively other insurances in other European countries in allocating budget for introducing the system in the elderly care process
